ClinicalMetric / Countries / Spain / advanced solid tumors
← 🇪🇸 Spain Trials
🇪🇸 Spain Country × Condition

advanced solid tumors Clinical Trials in Spain

Active clinical trials for advanced solid tumors with research sites in Spain. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇪🇸 Spain

Active Trials in Spain (2)

NCT06795412 Phase 1, Phase 2
Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Enrollment
220 pts
Country
🇪🇸 Spain
Pyxis Oncology, Inc
View Trial →
NCT07266428 Phase 1, Phase 2
Recruiting

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

Enrollment
170 pts
Country
🇪🇸 Spain
Ottimo Pharma Limited
View Trial →

Frequently Asked Questions

How many advanced solid tumors clinical trials are active in Spain?
There are currently 2 active clinical trials for advanced solid tumors with sites in Spain, of which 2 are actively recruiting patients.
How can I join a advanced solid tumors clinical trial in Spain?
To join a advanced solid tumors clinical trial in Spain, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Spain directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are advanced solid tumors trials in Spain?
Active advanced solid tumors trials in Spain span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Spain Trials → Global advanced solid tumors Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology